chr19-35249065-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000605618.6(LSR):c.43C>T(p.His15Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000529 in 1,569,246 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000605618.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LSR | NM_205834.4 | c.43C>T | p.His15Tyr | missense_variant | 1/10 | ENST00000605618.6 | NP_991403.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LSR | ENST00000605618.6 | c.43C>T | p.His15Tyr | missense_variant | 1/10 | 1 | NM_205834.4 | ENSP00000474797.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 21AN: 165344Hom.: 1 AF XY: 0.000187 AC XY: 17AN XY: 90852
GnomAD4 exome AF: 0.0000565 AC: 80AN: 1417066Hom.: 1 Cov.: 31 AF XY: 0.0000813 AC XY: 57AN XY: 701516
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152180Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2022 | The c.187C>T (p.H63Y) alteration is located in exon 1 (coding exon 1) of the LSR gene. This alteration results from a C to T substitution at nucleotide position 187, causing the histidine (H) at amino acid position 63 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 24, 2023 | Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The tyrosine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 2407782). This variant has not been reported in the literature in individuals affected with LSR-related conditions. This variant is present in population databases (rs557558088, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 63 of the LSR protein (p.His63Tyr). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at